Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for …
KM Chow, WZ So, HJ Lee, A Lee, DWT Yap… - European Urology, 2023 - Elsevier
Context Whether prostate-specific membrane antigen positron emission tomography (PSMA-
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …
PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate …
Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT
M Eiber, K Herrmann, J Calais… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented
accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly …
accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly …
Semiautomatically quantified tumor volume using 68Ga-PSMA-11 PET as a biomarker for survival in patients with advanced prostate cancer
R Seifert, K Herrmann, J Kleesiek… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–targeting PET imaging is becoming the
reference standard for prostate cancer staging, especially in advanced disease. Yet, the …
reference standard for prostate cancer staging, especially in advanced disease. Yet, the …
Prostate-specific membrane antigen theranostics: therapy with lutetium-177
J Ferdinandus, J Violet, S Sandhu… - Current opinion in …, 2018 - journals.lww.com
Several studies suggest that radionuclide therapy with 177 Lu-PSMA has high activity and is
well tolerated. Crucial to establishing this treatment in routine clinical management will be …
well tolerated. Crucial to establishing this treatment in routine clinical management will be …
Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT
Purpose This study proposes an automated prostate cancer (PC) lesion characterization
method based on the deep neural network to determine tumor burden on 68 Ga-PSMA-11 …
method based on the deep neural network to determine tumor burden on 68 Ga-PSMA-11 …
qPSMA: semiautomatic software for whole-body tumor burden assessment in prostate cancer using 68Ga-PSMA11 PET/CT
Our aim was to introduce and validate qPSMA, a semiautomatic software package for whole-
body tumor burden assessment in prostate cancer patients using 68Ga-prostate-specific …
body tumor burden assessment in prostate cancer patients using 68Ga-prostate-specific …
[HTML][HTML] Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning
N Capobianco, L Sibille, M Chantadisai… - European journal of …, 2022 - Springer
Abstract Purpose In PSMA-ligand PET/CT imaging, standardized evaluation frameworks and
image-derived parameters are increasingly used to support prostate cancer staging. Clinical …
image-derived parameters are increasingly used to support prostate cancer staging. Clinical …
[HTML][HTML] Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
L Thomas, C Balmus, H Ahmadzadehfar, M Essler… - Pharmaceuticals, 2017 - mdpi.com
Purpose: Bone scintigraphy is the standard of reference in bone metastases in prostate
cancer patients. However, new radiotracers employed in prostate-specific membrane …
cancer patients. However, new radiotracers employed in prostate-specific membrane …
[HTML][HTML] Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index
S Lindgren Belal, M Larsson, J Holm… - European journal of …, 2023 - Springer
Purpose Consistent assessment of bone metastases is crucial for patient management and
clinical trials in prostate cancer (PCa). We aimed to develop a fully automated convolutional …
clinical trials in prostate cancer (PCa). We aimed to develop a fully automated convolutional …
Theranostics for advanced prostate cancer: current indications and future developments
Abstract Context Advanced prostate cancer (PCa) is a prominent cause of cancer death in
men; positron emission tomography (PET) imaging may play a relevant role in detecting …
men; positron emission tomography (PET) imaging may play a relevant role in detecting …